title: Asymmetry of Bispectral Index (BIS) in severe brain-injured patients treated by barbiturates with unilateral or diffuse brain injury.
abstract: OBJECTIVE
  Bispectral index (BIS) may be used in traumatic brain-injured patients (TBI) with intractable intracranial hypertension to adjust barbiturate infusion but it is obtained through a unilateral frontal electrode. The objective of this study was to evaluate differences in BIS between hemispheres in two groups: unilateral frontal (UFI) and diffuse (DI) injured.
  
  
  METHODS
  Prospective monocenter observational study in 24 TBI treated with barbiturates: 13 UFI and 11 DI. Simultaneous BIS and EEG was recorded for 1h. Goal of monitoring was a left BIS between 5 and 15. Biases in BIS were considered as clinically relevant if greater than 5. Differences in biases were interpreted from both statistical (Mann-Whitney test) and clinical points of view.
  
  
  RESULTS
  Mean BIS in the two hemispheres remained in the same monitoring range. There were statistic and clinical differences in some values in the two groups of patients (15% of bias greater than I5I in UFI group and 10% in DI group). BIS monitoring allowed the adequate number of bursts/minutes to be predicted in 18 patients and did not detect an overdosage in 2.
  
  
  CONCLUSIONS
  While asymmetric BIS values in TBI patients occur whatever the kind of injury, they were not found to be clinically relevant in most of these heavily sedated patients. Asymmetrical BIS monitoring might be sufficient to monitor barbiturate infusion in TBI provided that the concordance between BIS and EEG is regularly checked.
authors.affiliation: Service de réanimation chirurgicale et traumatologique, SAR 1, hôpital Pellegrin, CHU de Bordeaux, place Amélie-Raba-Léon, Bordeaux, France. vincent.cottenceau@chu-bordeaux.fr
authors.forename: V
authors.initials: V
authors.lastname: Cottenceau
authors.forename: F
authors.initials: F
authors.lastname: Masson
authors.forename: A
authors.initials: A
authors.lastname: Soulard
authors.forename: L
authors.initials: L
authors.lastname: Petit
authors.forename: D
authors.initials: D
authors.lastname: Guehl
authors.forename: J-F
authors.initials: JF
authors.lastname: Cochard
authors.forename: C
authors.initials: C
authors.lastname: Pinaquy
authors.forename: A
authors.initials: A
authors.lastname: Leger
authors.forename: F
authors.initials: F
authors.lastname: Sztark
mesh_terms: D000328:Adult; D000368:Aged; D001463:Barbiturates / Q000627:therapeutic use*; D001930:Brain Injuries / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D016292:Procedural Sedation; D056805:Consciousness Monitors / Q000706:statistics & numerical data*; D004569:Electroencephalography; D004576:Electromyography; D005260:Female; D005625:Frontal Lobe / Q000293:injuries; D007839:Functional Laterality / Q000502:physiology; D015600:Glasgow Coma Scale; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000379:methods; D019635:Neurosurgical Procedures; D011446:Prospective Studies; D014057:Tomography, X-Ray Computed
chemical_list: D001463:Barbiturates; D006993:Hypnotics and Sedatives